Scarica l'app Stockscreener
1.21
14.18%
-0.20
Dopo l'orario di chiusura:
1.18
-0.03
-2.48%
Precedente Chiudi:
$1.41
Aprire:
$1.34
Volume 24 ore:
291.41K
Relative Volume:
0.03
Capitalizzazione di mercato:
$1.23M
Reddito:
-
Utile/perdita netta:
$-16.89M
Rapporto P/E:
-0.0579
EPS:
-20.8847
Flusso di cassa netto:
$-16.44M
1 W Prestazione:
-33.52%
1M Prestazione:
-65.72%
6M Prestazione:
+40.70%
1 anno Prestazione:
-81.78%
Intervallo 1D:
$1.15
$1.34
Intervallo di 1 settimana:
$1.15
$1.95
Portata 52W:
$0.25
$9.086
Glucotrack Inc Stock (GCTK) Company Profile
Nome
Glucotrack Inc
Settore
Industria
Telefono
972 (8) 675-7878
Indirizzo
301 RT 17 NORTH, RUTHERFORD
Compare GCTK vs ISRG, BDX, RMD, MDLN, ALC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
1.21 | 1.85M | 0 | -16.89M | -16.44M | -20.88 |
ISRG
Intuitive Surgical Inc
|
391.95 | 143.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
176.80 | 50.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
218.89 | 32.02B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.61 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
63.76 | 31.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
Glucotrack Inc Borsa (GCTK) Ultime notizie
Lokahi announces health platform to compare GLP-1 outcomes - Investing.com
Lokahi announces health platform to compare GLP-1 outcomes By Investing.com - Investing.com Canada
Patients may soon compare medication experiences with others like them. - Stock Titan
Form 8K GlucoTrack Inc For: 28 September By Investing.com - Investing.com Nigeria
Glucotrack announces amendments to warrant and note agreements, repays bridge notes - Investing.com
Glucotrack announces pricing of public offering - Medical Buyer
Lōkahi Therapeutics™ Expands ai2 Pipeline™ Program Through Collaboration with Pepperdine E2B™ - The National Law Review
Emerging Growth DRK GLND APUS GCTK Stocks in the News - marketscreener.com
Form 424B5 GlucoTrack Inc For: 24 September By Investing.com - Investing.com Canada
GlucoTrack Announces Debt-Reducing Public Equity Offering - TipRanks
Glucotrack Prices $3.1 Million Registered Direct Offering of Stock and Pre-Funded Warrants - TradingView
GlucoTrack Shares More Than Double After Subsidiary Lands First Fee-for-Service Deal - finance.biggo.com
What's Going On With GlucoTrack Shares On Thursday? - Benzinga
Medical device developer Glucotrack Inc. announces pricing of $3M public offering - ROI-NJ
GlucoTrack Jumps as New Platform Commercialization News Appears to Outweigh Fresh Offering - Moomoo
Glucotrack prices $3.1 million public offering at $2.04/share - Investing.com India
GCTK Stock Slides As Lokahi Platform And LT-100 Gain Steam - StocksToTrade
GCTK Stock Draws Traders As Lokahi Strategy Takes Shape - timothysykes.com
Lokahi Therapeutics and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai-2 Platform Growth and Clinical Development Priorities - marketscreener.com
GlucoTrack, Inc. Announces Pricing of $3 Mill - Moomoo
GCTK Stock Draws Traders As Lokahi Pipeline And ai² Platform Advance - timothysykes.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
GCTK Stock Draws Traders As Lokahi Pivot Accelerates - StocksToTrade
GCTK Stock Draws Traders As Lokahi Platform And LT-100 Advance - timothysykes.com
Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket - Benzinga
GlucoTrack Stock Surges 80% After Hours on Brain Tumor DealGlucoTrack (NASDAQ:GCTK) - Benzinga
Lōkahi Therapeutics™ and GlucoTrack CEO Erik - Moomoo
Lōkahi Therapeutics™ Advances its Proprietary ai² PIPELINE (formerly ai² Futures Lab) Process from Internal Asset Engine to Revenue-Generating Platform - 01net
Trending Stocks Today | Glucotrack Shoots up 92.61% Post-Market - Moomoo
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Form 4 GlucoTrack Inc For: 23 September By Investing.com - Investing.com Canada
Form 8K GlucoTrack Inc For: 23 September - Investing.com India
Form 8K GlucoTrack Inc For: 23 September By Investing.com - Investing.com Canada
GlucoTrack and Lōkahi Outline Post-Merger Strategic Focus - TipRanks
Form 4 GlucoTrack Inc For: 23 September - Investing.com India
Shelved drug trove powers Glucotrack (NASDAQ: GCTK) ai² search for new therapies - Stock Titan
Glucotrack issues strategic update: LT-100 clinical study targeted, ai² platform expands university network - TradingView
Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities - Business Wire
GlucoTrack Director Resigns Amid Merger Conflict Concerns - The Globe and Mail
Form 8K GlucoTrack Inc For: 18 September By Investing.com - Investing.com Nigeria
Glucotrack director Paul V. Goode resigns citing potential conflict of interest - Investing.com
Board member quits Glucotrack (GCTK) over merger conflict - Stock Titan
Glucotrack, Inc. Announces Resignation of Paul V. Goode from the Board of Directors, Effective September 14, 2026 - marketscreener.com
Alabama students identified more than 45 potential treatments - Stock Titan
Glucotrack (NASDAQ: GCTK) registers shares equal to 5,442% of stock outstanding - Stock Titan
Glucotrack shareholders approve stock issuance proposals and amend warrant terms By Investing.com - Investing.com South Africa
Form 8K GlucoTrack Inc For: 14 September By Investing.com - Investing.com Canada
Glucotrack shareholders approve stock issuance proposals and amend warrant terms - Investing.com
Form 8K GlucoTrack Inc For: 11 September By Investing.com - Investing.com Australia
Why Is GlucoTrack (GCTK) in Focus? - kalkinemedia.com
GCTK Stock Is Soaring Today — What Is Fueling The Surge? - Stocktwits
Glucotrack Inc Azioni (GCTK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.06%
0.87%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):